Literature DB >> 24078717

Dopamine agonist withdrawal syndrome (DAWS) in a patient with a microprolactinoma.

Benedetta Demartini1, Lucia Ricciardi, Alexandra Ward, Mark J Edwards.   

Abstract

Entities:  

Keywords:  ENDOCRINOLOGY; PHARMACOLOGY; PSYCHOLOGY

Mesh：

Substances：

Year:  2013        PMID： 24078717     DOI： 10.1136/jnnp-2013-306043

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

1.  Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome without impulse control disorder or drug abuse.

Authors:  Yasushi Shimo; Asuka Nakajima; Nobutaka Hattori
Journal:  Neurol Sci       Date:  2014-11-02       Impact factor: 3.307

2.  Impact of primary medical or surgical therapy on prolactinoma patients' BMI and metabolic profile over the long-term.

Authors:  Lukas Andereggen; Janine Frey; Robert H Andres; Markus M Luedi; Jan Gralla; Gerrit A Schubert; Jürgen Beck; Luigi Mariani; Emanuel Christ
Journal:  J Clin Transl Endocrinol       Date:  2021-06-17

3.  First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center.

Authors:  L Andereggen; J Frey; R H Andres; M M Luedi; M El-Koussy; H R Widmer; J Beck; L Mariani; R W Seiler; E Christ
Journal:  J Endocrinol Invest       Date:  2021-04-13       Impact factor: 4.256
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.